{"id":"W2787457224","doi":"10.1158/1535-7163.targ-17-a082","title":"Abstract A082: A phase I study of the MDM2 antagonist RO6839921, a pegylated intravenous prodrug of idasanutlin, in patients with AML","year":2018,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Nausea; Pharmacology; Prodrug; Dosing; Vomiting; Internal medicine; Pharmacodynamics; Phases of clinical research; Pharmacokinetics; Gastroenterology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000630946,0.001051207,0.001211124,0.0002798975,0.00027755,0.0006362728,0.0005298968,0.0007273233,0.002182286],"category_scores_gemma":[0.0004725062,0.0003607786,0.0005751734,0.0002348226,0.0004484861,0.0004787427,0.0002721417,0.001909004,0.0008627993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004960856,"about_ca_system_score_gemma":0.0006975769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000530093,"about_ca_topic_score_gemma":0.0006580298,"domain_scores_codex":[0.9997724,0.00009616751,0.00001584208,0.00004696396,0.00002610266,0.00004257525],"domain_scores_gemma":[0.9997216,0.0000398095,0.00004702817,0.00002696293,0.00001841899,0.0001460714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3394997,0.08368053,0.01334561,0.001044402,0.001063234,0.001338739,0.0006844575,0.004336961,0.3852236,0.0004563094,0.005325045,0.1640014],"study_design_scores_gemma":[0.2127779,0.7337691,0.02038919,0.00003355289,0.000405718,0.001317274,0.00009568234,0.002113548,0.02348845,0.0001832299,0.005391567,0.00003478809],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961875,0.0007811338,0.0004612372,0.0002137411,0.00003386642,0.0007794687,0.0004547167,0.00006232096,0.001026071],"genre_scores_gemma":[0.9944858,0.000591448,0.001143528,0.0003105944,0.00008601099,0.0007488235,0.001035472,0.00002518312,0.001573059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002182286,"threshold_uncertainty_score":0.007300436,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01546502045544257,"score_gpt":0.2865701823240733,"score_spread":0.2711051618686307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}